The inaugural New England Sarcoma Symposium, a joint effort between the Roger Williams Cancer Center and the Kristen Ann Carr Fund, took place in March, 2011 in Providence, Rhode Island. The academic program was designed to benefit a broad range of cancer experts, including surgeons, medical oncologists, gastroenterologists, and the corresponding trainees, placing special emphasis on the importance of multidisciplinary collaboration for achieving optimal sarcoma patient outcomes.

The lectures, which can be viewed below, covered extremity and retroperitoneal soft tissue sarcomas, in addition to gastrointestinal stromal tumors. You can also see photographs from the event here.

• Soft Tissue Sarcoma Management
• Murray F. Brennan, MD
• Progress Made and Lessons Learned
• Vice President for International Programs & Benno C. Schmidt
• Chair in Clinical Oncology
• Memorial Sloan-Kettering Cancer Center

• Medical and Surgical Management of Metastatic Gastrointestinal Stromal Tumor
• Chandrajit Raut, MD
• Dana Farber Cancer Institute
• Disease Center Leader, Surgical Oncology
• Assistant Professor of Surgery, Harvard Medical School

• Surgical Management of Gastrointestinal Stromal Tumor (GIST)
• Russell S. Berman, MD
• Director, Surgical Residency Training Program
• Assistant Professor of Surgery
• New York University Langone Medical Center

• Radiation Therapy for Soft Tissue Sarcoma
• David Kirsch, MD, PhD
• Associate Professor of Radiation Oncology
• Assistant Professor of Pharmacology & Cancer Biology
• Duke University School of Medicine

• Systemic Therapy for Soft Tissue Sarcoma
• Robert G. Maki, MD, PhD
• Senior Faculty, Medicine, Pediatrics, Hematology and Medical Oncology
• The Mount Sinai Medical Center

• Multimodality Management of Retroperitoneal Sarcoma
• Rebecca Gladdy, MD, PhD
• Assistant Professor of Surgery
• University of Toronto

• Identification of Targets for Sarcoma Therapy
• Jonathan A. Fletcher, MD
• Associate Professor of Pathology
• Dana Farber Cancer Institute

• Surgical Resection of Sarcoma Metastases
• Steven C. Katz, MD
• Assistant Professor of Surgery
• Roger Williams Cancer Center

• Future of Sarcoma Therapy: Development of Novel Agents
• Jonathan J. Lewis, MD, PhD
• Chief Executive Officer and Chief Medical Officer
• Ziopharm Oncology